{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:34:09Z","timestamp":1793406849022,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.kint.2017.07.018","type":"journal-article","created":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T01:01:51Z","timestamp":1506128511000},"page":"491-500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients"],"prefix":"10.1016","volume":"93","author":[{"given":"Sebastiaan","family":"Heidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert W.","family":"Haasnoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon J.","family":"van Rood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian D.","family":"Witvliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans H.J.","family":"Claas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2017.07.018_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00007890-199209000-00001","article-title":"Alloimmunization, memory, and the interpretation of crossmatch results for renal transplantation","volume":"54","author":"Scornik","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2017.07.018_bib2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.2215\/CJN.05930615","article-title":"Approach to the highly sensitized kidney transplant candidate","volume":"11","author":"Keith","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.07.018_bib3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.07.018_bib4","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1111\/j.1600-6143.2009.02745.x","article-title":"Successful expansion of the living donor pool by alternative living donation programs","volume":"9","author":"Roodnat","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2017.07.018_bib5","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1681\/ASN.2013070784","article-title":"New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes","volume":"25","author":"Israni","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.07.018_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1600-6143.2007.02039.x","article-title":"Two novel assays of alloantibody-secreting cells demonstrating resistance to desensitization with IVIG and rATG","volume":"8","author":"Perry","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2017.07.018_bib7","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/ajt.12220","article-title":"A\u00a0single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function","volume":"13","author":"Kamburova","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2017.07.018_bib8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/TP.0b013e3182590d2e","article-title":"Lack of effect in desensitization with intravenous immunoglobulin and rituximab in highly sensitized patients","volume":"94","author":"Marfo","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2017.07.018_bib9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2009.02985.x","article-title":"Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation","volume":"10","author":"Gloor","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2017.07.018_bib10","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/ajt.13061","article-title":"The new OPTN kidney allocation policy: potential for inequitable access among highly sensitized patients","volume":"15","author":"Bray","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2017.07.018_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humimm.2016.08.007","article-title":"Old versus new: progress in reaching the goals of the new kidney allocation system","volume":"78","author":"Wang","year":"2017","journal-title":"Hum Immunol"},{"key":"10.1016\/j.kint.2017.07.018_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.trim.2015.08.006","article-title":"The 25th anniversary of the Eurotransplant Acceptable Mismatch program for highly sensitized patients","volume":"33","author":"Heidt","year":"2015","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.kint.2017.07.018_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/01.TP.0000129260.86766.67","article-title":"The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome","volume":"78","author":"Claas","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2017.07.018_bib14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/00007890-198612000-00007","article-title":"Immunoglobulin class and specificity of antibodies causing positive T cell crossmatches: relationship to renal transplant outcome","volume":"42","author":"Chapman","year":"1986","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2017.07.018_bib15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1600-6143.2007.02072.x","article-title":"Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation","volume":"8","author":"Lefaucheur","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2017.07.018_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.07.018_bib17","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1600-6143.2011.03985.x","article-title":"Pretransplant donor-specific HLA class-I and -II antibodies are associated with an increased risk for kidney graft failure","volume":"12","author":"Otten","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2017.07.018_bib18","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/ajt.13770","article-title":"Changes in deceased donor kidney transplantation one year after KAS implementation","volume":"16","author":"Stewart","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2017.07.018_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.trim.2014.09.008","article-title":"The PROCARE consortium: toward an improved allocation strategy for kidney allografts","volume":"31","author":"Otten","year":"2014","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.kint.2017.07.018_bib20","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJM199812033392302","article-title":"The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors","volume":"339","author":"Burlingham","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.07.018_bib21","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1126\/science.3051377","article-title":"Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life","volume":"241","author":"Claas","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.kint.2017.07.018_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1432-2277.2004.tb00379.x","article-title":"HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates","volume":"17","author":"Duquesnoy","year":"2004","journal-title":"Transpl Int"},{"key":"10.1016\/j.kint.2017.07.018_bib23","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2017.07.018_bib24","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1111\/j.1600-6143.2006.01503.x","article-title":"Post-transplant anti-HLA class II antibodies as risk factor for late kidney allograft failure","volume":"6","author":"Campos","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2017.07.018_bib25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/ajt.13167","article-title":"Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level?","volume":"15","author":"Duquesnoy","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2017.07.018_bib26","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1111\/ajt.13341","article-title":"The synergistic effect of class II HLA epitope-mismatch and nonadherence on acute rejection and graft survival","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2017.07.018_bib27","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1111\/ajt.12478","article-title":"Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes","volume":"13","author":"Wiebe","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2017.07.018_bib28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1744-313X.2008.00800.x","article-title":"HLA antibody testing: a tool to facilitate not to prevent organ transplantation","volume":"35","author":"Claas","year":"2008","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.kint.2017.07.018_bib29","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/01.tp.0000261108.27421.bc","article-title":"Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility","volume":"83","author":"Doxiadis","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2017.07.018_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/01.tp.0000251781.36117.27","article-title":"Multicenter analysis of kidney preservation","volume":"83","author":"Opelz","year":"2007","journal-title":"Transplantation"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253817305495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253817305495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:49:55Z","timestamp":1758761395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253817305495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0085253817305495"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2017.07.018","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2017.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}